• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

4例遗传性黄嘌呤尿症患者嘌呤代谢的生化研究

Biochemical studies on the purine metabolism of four cases with hereditary xanthinuria.

作者信息

Kojima T, Nishina T, Kitamura M, Hosoya T, Nishioka K

出版信息

Clin Chim Acta. 1984 Feb 28;137(2):189-98. doi: 10.1016/0009-8981(84)90179-7.

DOI:10.1016/0009-8981(84)90179-7
PMID:6423323
Abstract

The purine metabolism of four cases with marked hypouricemia (serum uric acid concentration of less than 0.018 mmol/l) from three Japanese families was investigated. Erythrocyte adenosine deaminase (EC 3.5.4.4) and purine-nucleoside phosphorylase (EC 2.4.2.1) activities of the patients were within the normal ranges. Urinary hypoxanthine and xanthine concentrations were 0.096-0.397 mmol/l and 0.743-1.717 mmol/l, respectively. Xanthine oxidase (EC 1.2.3.2) activities in the jejunal mucosa of the two normal controls were 0.257 and 0.283 units/g protein, while those of three of the patients were extremely low and could not be determined. The findings of these biochemical features may indicate that the four patients have hereditary xanthinuria. In order to study the purine metabolism in the hypouricemic condition of this disorder, a single oral dose of allopurinol (4-hydroxypyrazolo[3,4-d]pyrimidine) was administered in one case. The excretion pattern of allopurinol and oxypurinol (4,6-dihydroxypyrazolo[3,4-d]pyrimidine) in the urine of the patient was similar to that of a normal control male. These data suggest that some residual enzyme activity may be functioning in vivo, although the presence of xanthine oxidase could not be detected.

摘要

对来自三个日本家庭的四名严重低尿酸血症患者(血清尿酸浓度低于0.018 mmol/l)的嘌呤代谢进行了研究。患者的红细胞腺苷脱氨酶(EC 3.5.4.4)和嘌呤核苷磷酸化酶(EC 2.4.2.1)活性在正常范围内。尿次黄嘌呤和黄嘌呤浓度分别为0.096 - 0.397 mmol/l和0.743 - 1.717 mmol/l。两名正常对照者空肠黏膜中的黄嘌呤氧化酶(EC 1.2.3.2)活性分别为0.257和0.283单位/克蛋白质,而三名患者的该酶活性极低,无法测定。这些生化特征的发现可能表明这四名患者患有遗传性黄嘌呤尿症。为了研究这种疾病低尿酸血症状态下的嘌呤代谢,对其中一名患者单次口服了别嘌醇(4 - 羟基吡唑并[3,4 - d]嘧啶)。该患者尿液中别嘌醇和氧嘌呤醇(4,6 - 二羟基吡唑并[3,4 - d]嘧啶)的排泄模式与正常对照男性相似。这些数据表明,尽管未检测到黄嘌呤氧化酶的存在,但体内可能仍有一些残余酶活性在发挥作用。

相似文献

1
Biochemical studies on the purine metabolism of four cases with hereditary xanthinuria.4例遗传性黄嘌呤尿症患者嘌呤代谢的生化研究
Clin Chim Acta. 1984 Feb 28;137(2):189-98. doi: 10.1016/0009-8981(84)90179-7.
2
The conversion of 4-hydroxypyrazolo[3,4-d]pyrimidine (allopurinol) into 4,6-dihroxypyrazolo[3,4-d]pyrimidine (Oxipurinol) in vivo in the absence of xanthine-oxen oxidoreductase.在缺乏黄嘌呤氧化还原酶的情况下,4-羟基吡唑并[3,4-d]嘧啶(别嘌呤醇)在体内转化为4,6-二羟基吡唑并[3,4-d]嘧啶(氧嘌呤醇)。
Biochem J. 1969 May;112(4):527-32. doi: 10.1042/bj1120527.
3
Hereditary xanthinuria is not so rare disorder of purine metabolism.遗传性黄嘌呤尿症并非嘌呤代谢中罕见的病症。
Nucleosides Nucleotides Nucleic Acids. 2018;37(6):324-328. doi: 10.1080/15257770.2018.1460478. Epub 2018 May 3.
4
[Hereditary xanthinuria. A clinical case report].[遗传性黄嘌呤尿症。一例临床病例报告]
Minerva Med. 1989 May;80(5):507-9.
5
Hereditary xanthinuria. Evidence for enhanced hypoxanthine salvage.遗传性黄嘌呤尿症。次黄嘌呤补救增强的证据。
J Clin Invest. 1987 Mar;79(3):847-52. doi: 10.1172/JCI112893.
6
[The total absence of xanthine oxidase activity. Apropos 2 cases of the nonfamilial incidence of xanthinuria].[黄嘌呤氧化酶活性完全缺失。关于2例非家族性黄嘌呤尿症的病例]
An Med Interna. 1991 Apr;8(4):181-4.
7
Liquid chromatography with multichannel ultraviolet detection used for studying disorders of purine metabolism.采用多通道紫外检测的液相色谱法用于研究嘌呤代谢紊乱。
Clin Chem. 1987 Nov;33(11):2052-6.
8
Decreased xanthine oxidase activities and increased urinary oxypurines in heterozygotes for hereditary xanthinuria.遗传性黄嘌呤尿症杂合子中黄嘌呤氧化酶活性降低及尿中氧嘌呤增加。
Clin Chim Acta. 1990 Apr 30;188(2):137-46. doi: 10.1016/0009-8981(90)90158-o.
9
Metabolism of pyrazinamide and allopurinol in hereditary xanthine oxidase deficiency.遗传性黄嘌呤氧化酶缺乏症中吡嗪酰胺和别嘌醇的代谢
Clin Chim Acta. 1989 Feb 28;180(2):169-75. doi: 10.1016/0009-8981(89)90348-3.
10
Two siblings with classical xanthinuria type 1: significance of allopurinol loading test.两名患有典型1型黄嘌呤尿症的兄弟姐妹:别嘌醇负荷试验的意义
Intern Med. 1998 Jan;37(1):77-82. doi: 10.2169/internalmedicine.37.77.

引用本文的文献

1
Monogenic Disorders of ROS Production and the Primary Anti-Oxidative Defense.单基因氧化还原产物异常和主要抗氧化防御异常。
Biomolecules. 2024 Feb 9;14(2):206. doi: 10.3390/biom14020206.
2
Xanthinuria Type 1 with a Novel Mutation in Xanthine Dehydrogenase and a Normal Endothelial Function.黄嘌呤尿症 1 型伴黄嘌呤氧化酶的新突变和正常的内皮功能。
Intern Med. 2022;61(9):1383-1386. doi: 10.2169/internalmedicine.7897-21. Epub 2022 May 1.
3
Association of Mutations Identified in Xanthinuria with the Function and Inhibition Mechanism of Xanthine Oxidoreductase.
黄嘌呤尿症中鉴定出的突变与黄嘌呤氧化还原酶的功能及抑制机制的关联
Biomedicines. 2021 Nov 20;9(11):1723. doi: 10.3390/biomedicines9111723.
4
The effect of dietary protein restriction in a case of molybdenum cofactor deficiency with mutation.饮食蛋白质限制对一例伴有突变的钼辅因子缺乏症的影响。
Mol Genet Metab Rep. 2021 Feb 1;26:100716. doi: 10.1016/j.ymgmr.2021.100716. eCollection 2021 Mar.
5
Differential regulation of hypoxanthine and xanthine by obesity in a general population.肥胖人群中黄嘌呤和次黄嘌呤的差异调节。
J Diabetes Investig. 2020 Jul;11(4):878-887. doi: 10.1111/jdi.13207. Epub 2020 Feb 9.
6
A case of xanthinuria type I with a novel mutation in xanthine dehydrogenase.一例伴有黄嘌呤脱氢酶新突变的Ⅰ型黄嘌呤尿症病例。
CEN Case Rep. 2016 Nov;5(2):158-162. doi: 10.1007/s13730-016-0216-3. Epub 2016 Mar 3.
7
Mutations associated with functional disorder of xanthine oxidoreductase and hereditary xanthinuria in humans.与人类黄嘌呤氧化还原酶功能紊乱及遗传性黄嘌呤尿症相关的突变。
Int J Mol Sci. 2012 Nov 21;13(11):15475-95. doi: 10.3390/ijms131115475.
8
Identification of two mutations in human xanthine dehydrogenase gene responsible for classical type I xanthinuria.鉴定人类黄嘌呤脱氢酶基因中导致经典I型黄嘌呤尿症的两个突变。
J Clin Invest. 1997 May 15;99(10):2391-7. doi: 10.1172/JCI119421.
9
Hereditary xanthinuria. Evidence for enhanced hypoxanthine salvage.遗传性黄嘌呤尿症。次黄嘌呤补救增强的证据。
J Clin Invest. 1987 Mar;79(3):847-52. doi: 10.1172/JCI112893.